Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
Background: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Clinical Ophthalmology and Research |
Subjects: | |
Online Access: | http://www.jcor.in/article.asp?issn=2320-3897;year=2021;volume=9;issue=2;spage=55;epage=58;aulast=Gandhi |
_version_ | 1818726197594423296 |
---|---|
author | Priyanka V Gandhi Omkar Telang Vrunda Morepatil |
author_facet | Priyanka V Gandhi Omkar Telang Vrunda Morepatil |
author_sort | Priyanka V Gandhi |
collection | DOAJ |
description | Background: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease (DED). Materials and Methods: This prospective, randomised, comparative, interventional study was conducted at a tertiary level academic centre on 240 eyes of 120 patients having DED, with Schirmer's test (without anesthesia) value less than or equal to 10mm and tear film breakup time (TBUT) less than or equal to 10 secs. After detailed ophthalmic examination, patients were randomly allocated in 4 different groups (A B C D). Group A were given 2% topical Rebamipide, group B received 2% topical Rebamipide with 0.05% topical Cyclosporine, group C were started on 0.1% topical Sodium Hyaluronate and group D were given 0.1% topical Sodium Hyaluronate with 0.05% cyclosporine. Each of these drops was given for 4 times a day for a period of 12 weeks. All patients were followed up after 2 weeks, 4 weeks and 12 weeks. Results: Out of 120 patients, 79 (65.83%) were female and 41 (34.16%) were male. The change in the mean schirmer's score and mean TBUT score was statistically significant in all four groups from baseline to 12 weeks (p<0.05). On comparing with each other, no significance difference was noted in any group. Conclusion: According to our study, 3 months of treatment with either 2% topical Rebamipide or 0.1% sodium hyaluronate is equally effective for DED and addition of 0.05% cyclosporine have no adjunctive role. |
first_indexed | 2024-12-17T21:54:23Z |
format | Article |
id | doaj.art-af8cf9778cf145eaa15e260d22ffd0b1 |
institution | Directory Open Access Journal |
issn | 2320-3897 |
language | English |
last_indexed | 2024-12-17T21:54:23Z |
publishDate | 2021-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Clinical Ophthalmology and Research |
spelling | doaj.art-af8cf9778cf145eaa15e260d22ffd0b12022-12-21T21:31:09ZengWolters Kluwer Medknow PublicationsJournal of Clinical Ophthalmology and Research2320-38972021-01-0192555810.4103/jcor.jcor_50_19Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye diseasePriyanka V GandhiOmkar TelangVrunda MorepatilBackground: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease (DED). Materials and Methods: This prospective, randomised, comparative, interventional study was conducted at a tertiary level academic centre on 240 eyes of 120 patients having DED, with Schirmer's test (without anesthesia) value less than or equal to 10mm and tear film breakup time (TBUT) less than or equal to 10 secs. After detailed ophthalmic examination, patients were randomly allocated in 4 different groups (A B C D). Group A were given 2% topical Rebamipide, group B received 2% topical Rebamipide with 0.05% topical Cyclosporine, group C were started on 0.1% topical Sodium Hyaluronate and group D were given 0.1% topical Sodium Hyaluronate with 0.05% cyclosporine. Each of these drops was given for 4 times a day for a period of 12 weeks. All patients were followed up after 2 weeks, 4 weeks and 12 weeks. Results: Out of 120 patients, 79 (65.83%) were female and 41 (34.16%) were male. The change in the mean schirmer's score and mean TBUT score was statistically significant in all four groups from baseline to 12 weeks (p<0.05). On comparing with each other, no significance difference was noted in any group. Conclusion: According to our study, 3 months of treatment with either 2% topical Rebamipide or 0.1% sodium hyaluronate is equally effective for DED and addition of 0.05% cyclosporine have no adjunctive role.http://www.jcor.in/article.asp?issn=2320-3897;year=2021;volume=9;issue=2;spage=55;epage=58;aulast=Gandhiconjunctival impression cytologycyclosporinerebamipidesodium hyaluronate |
spellingShingle | Priyanka V Gandhi Omkar Telang Vrunda Morepatil Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease Journal of Clinical Ophthalmology and Research conjunctival impression cytology cyclosporine rebamipide sodium hyaluronate |
title | Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease |
title_full | Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease |
title_fullStr | Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease |
title_full_unstemmed | Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease |
title_short | Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease |
title_sort | comparing the efficacy of 2 topical rebamipide and 0 1 topical sodium hyaluronate with or without 0 05 topical cyclosporine in patients with dry eye disease |
topic | conjunctival impression cytology cyclosporine rebamipide sodium hyaluronate |
url | http://www.jcor.in/article.asp?issn=2320-3897;year=2021;volume=9;issue=2;spage=55;epage=58;aulast=Gandhi |
work_keys_str_mv | AT priyankavgandhi comparingtheefficacyof2topicalrebamipideand01topicalsodiumhyaluronatewithorwithout005topicalcyclosporineinpatientswithdryeyedisease AT omkartelang comparingtheefficacyof2topicalrebamipideand01topicalsodiumhyaluronatewithorwithout005topicalcyclosporineinpatientswithdryeyedisease AT vrundamorepatil comparingtheefficacyof2topicalrebamipideand01topicalsodiumhyaluronatewithorwithout005topicalcyclosporineinpatientswithdryeyedisease |